Evidence map›Paper›PMID 34063648›Full record

ReviewCancers2021

Does Cancer Biology Rely on Parrondo's Principles?

Jean-Pascal Capp, Aurora M Nedelcu, Antoine M Dujon, Benjamin Roche, Francesco Catania, Beata Ujvari, Catherine Alix-Panabières, Frédéric Thomas

Abstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jean-Pascal CappToulouse Biotechnology Institute, University of Toulouse, INSA, CNRS, INRAE, 31400 Toulouse, France.ORCID 0000-0002-6470-079X
Aurora M NedelcuDepartment of Biology, University of New Brunswick, P.O. Box 4400, Fredericton, NB E3B 5A3, Canada.
Antoine M DujonCentre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Deakin, VIC 3216, Australia.ORCID 0000-0002-1579-9156
Benjamin RocheCREEC/CANECEV, MIVEGEC (CREES), Centre de Recherches Ecologiques et Evolutives sur le Cancer, University of Montpellier, CNRS, IRD, 34000 Montpellier, France.
Francesco CataniaInstitute for Evolution and Biodiversity, University of Münster, Hüfferstrasse 1, 48149 Münster, Germany.
Beata UjvariCentre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Deakin, VIC 3216, Australia.
Catherine Alix-PanabièresCREEC/CANECEV, MIVEGEC (CREES), Centre de Recherches Ecologiques et Evolutives sur le Cancer, University of Montpellier, CNRS, IRD, 34000 Montpellier, France.ORCID 0000-0002-6401-2903
Frédéric ThomasCREEC/CANECEV, MIVEGEC (CREES), Centre de Recherches Ecologiques et Evolutives sur le Cancer, University of Montpellier, CNRS, IRD, 34000 Montpellier, France.

Funding

Agence Nationale de la Recherche ANR-18-CE35-0009MAVA Foundation NA
6 · The paper itself

Abstract

Many aspects of cancer biology remain puzzling, including the proliferative and survival success of malignant cells in spite of their high genetic and epigenetic instability as well as their ability to express migrating phenotypes and/or enter dormancy despite possible fitness loss. Understanding the potential adaptive value of these phenotypic traits is confounded by the fact that, when considered separately, they seem to be rather detrimental at the cell level, at least in the short term. Here, we argue that cancer's biology and success could frequently be governed by processes underlying Parrondo's paradox, whereby combinations of intrinsically losing strategies may result in winning outcomes. Oncogenic selection would favor Parrondo's dynamics because, given the environmental adversity in which malignant cells emerge and evolve, alternating between various less optimal strategies would represent the sole viable option to counteract the changing and deleterious environments cells are exposed to during tumorigenesis. We suggest that malignant processes could be viewed through this lens, and we discuss how Parrondo's principles are also important when designing therapies against cancer.

Indexed as

cancerdormancymetastasisParrondo’s paradoxtherapy

Identifiers

PMID34063648
PMCPMC8125342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.